Stock Analysts’ updated eps estimates for Thursday, August 10th:
African Barrick Gold (NASDAQ:ABGLF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Acacia Mining plc is a mining company which acquires and explores primarily for gold. The Company’s producing mines consists of Bulyanhulu, Buzwagi and North Mara and a portfolio of exploration projects in Tanzania, Kenya and Burkina Faso. Acacia Mining plc, formerly known as African Barrick Gold plc, is based in London, United Kingdom. “
Armstrong Flooring (NYSE:AFI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Armstrong Flooring, Inc. is engaged in the design and manufacture of flooring solutions primarily in North America. Armstrong Flooring, Inc. is headquatered in Lancaster, Pa. “
AppFolio (NASDAQ:APPF) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $42.00 price target on the stock. According to Zacks, “AppFolio, Inc. offers cloud-based software solutions for property management and legal industries. It offers AppFolio Property Manager, a solution for the property managers including activities of posting and tracking tenant vacancies, handling the entire leasing process electronically, administering maintenance and repairs with their vendor networks, managing accounting and reporting to property owners. MyCase solution for practitioners and small law firms, providing time tracking, billing and payments, client communication, coordination with other lawyers and support staff, legal document management and assembly and general office administration services. Value+ services include Websites and electronic payment services. AppFolio, Inc. is headquartered Goleta, California. “
Amtech Systems (NASDAQ:ASYS) had its outperform rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $13.50 target price on the stock, up from their previous target price of $10.50.
BeiGene (NASDAQ:BGNE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company’s clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands. “
Chemours Company (The) (NYSE:CC) had its buy rating reaffirmed by analysts at Argus. They currently have a $55.00 target price on the stock, up from their previous target price of $50.00.
Coca-Cola European Partners PLC (NYSE:CCE) had its hold rating reaffirmed by analysts at Susquehanna Bancshares Inc.
Cidara Therapeutics (NASDAQ:CDTX) was given a $15.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.
Core-Mark Holding (NASDAQ:CORE) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Core-Mark is one of the largest broad-line, full-service wholesale distributors of packaged consumer products to the convenience retail industry in North America. The Core-Mark provides distribution and logistics services as well as marketing programs to retail locations in states and five Canadian provinces through distribution centers. Core-Mark services traditional convenience retailers, grocers, mass merchandisers, drug, liquor and specialty stores, and other stores that carry consumer packaged goods. “
Crocs (NASDAQ:CROX) had its positive rating reaffirmed by analysts at Susquehanna Bancshares Inc. The firm currently has a $8.00 price target on the stock, up from their previous price target of $7.00.
Community Trust Bancorp (NASDAQ:CTBI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Community Trust Financial Services Corporation was incorporated under the laws for the purpose of becoming a bank holding company for Community Trust Bank. The Company is intended to facilitate the Bank’s ability to serve its customers’ requirements for financial services. The primary activity of the Company currently is, and is expected to remain for the foreseeable future, the ownership and operation of the Bank. “
CatchMark Timber Trust (NYSE:CTT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CatchMark Timber Trust Inc. is a real estate investment trust. The Company is involved in the ownership, management, acquisition and disposition of timberlands primarily in the United States. CatchMark Timber Trust Inc. is based in Norcross, Georgia. “
DLH Holdings Corp. (NASDAQ:DLHC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $6.50 target price on the stock. According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “
Evertec (NYSE:EVTC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Evertec, Inc. is engaged in transaction processing business primarily in Latin America and the Caribbean. The Company operates through divisions which consist of Merchant Acquiring Solutions, Payment Processing and Business Solutions. It offers ATH network, payment processing, card products processing, electronic benefit transfer services, information technology services, database management services, printing centre and document mailing, cash processing, business processes outsourcing services as well as payment solutions, point-of-sale systems and accessories to receive payments. Evertec, Inc. is based in San Juan, Puerto Rico. “
Second Sight Medical Products (NASDAQ:EYES) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California. “
FelCor Lodging Trust (NYSE:FCH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “FelCor Lodging Trust Inc., a real estate investment trust, is one of the nation’s largest owners of upper-upscale, all-suite hotels. FelCor’s diversified portfolio of hotels and resorts are flagged under global brands such as: Doubletree ®, Embassy Suites Hotels®, Hilton®, Fairmont®, Marriott®, Renaissance®, Sheraton®, Westin® and Holiday Inn®. FelCor Lodging Trust Inc., formerly known as FelCor Suite Hotels, Inc., is based in Irving, Texas. “
Home Depot, Inc. (The) (NYSE:HD) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $182.00 target price on the stock.
Hertz Global Holdings (NYSE:HTZ) had its buy rating reaffirmed by analysts at MKM Partners. MKM Partners currently has a $22.00 target price on the stock.
Jack In The Box (NASDAQ:JACK) had its outperform rating reissued by analysts at Wells Fargo & Company. They currently have a $120.00 target price on the stock.
Deutsche Lufthansa AG (ETR:LHA) was given a €21.00 ($24.71) price target by analysts at Commerzbank Ag. The firm currently has a neutral rating on the stock.
Lumentum Holdings (NASDAQ:LITE) had its buy rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $72.00 target price on the stock, up from their previous target price of $63.00.
Lumentum Holdings (NASDAQ:LITE) had its strong-buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $80.00 target price on the stock.
The Medicines (NASDAQ:MDCO) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $54.00 price target on the stock, down from their previous price target of $62.00.
Nexeo Solutions (NASDAQ:NXEO) had its hold rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $8.50 price target on the stock, down from their previous price target of $9.50.
Puma Biotechnology (NYSE:PBYI) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $110.00 price target on the stock, down from their previous price target of $118.00.
Royal Gold (NASDAQ:RGLD) (TSE:RGL) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $105.00 target price on the stock, up from their previous target price of $99.00.
TripAdvisor (NASDAQ:TRIP) had its neutral rating reaffirmed by analysts at UBS AG. The firm currently has a $43.00 price target on the stock, down from their previous price target of $50.00.
TripAdvisor (NASDAQ:TRIP) had its neutral rating reaffirmed by analysts at Susquehanna Bancshares Inc. The firm currently has a $32.00 target price on the stock, down from their previous target price of $40.00.
WAVE Life Sciences (NASDAQ:WVE) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $40.00 price target on the stock, down from their previous price target of $42.00.
DENTSPLY SIRONA (NASDAQ:XRAY) had its neutral rating reiterated by analysts at UBS AG. The firm currently has a $59.00 target price on the stock, down from their previous target price of $62.00.
